Blackstone-Affiliated Entities Sell Over $1.1 Billion in Medline Shares
Summary
Blackstone-affiliated 10% owners disposed of over 28 million shares of Medline Inc. Class A Common Stock for approximately $1.14 billion as part of a previously announced secondary offering.
Key Events
-
Major Share Disposition
Blackstone-affiliated 10% owners, including BX Mozart ML-2 Holdco L.P., sold 27,852,986 shares of Class A Common Stock in open market transactions.
-
Significant Proceeds
The open market sales generated approximately $1,128,268,757 at an average price of $40.51 per share on March 10, 2026.
-
Part of Secondary Offering
This sale is part of the secondary offering of 75 million shares by major private equity shareholders, which was priced on March 5, 2026, and closed on March 10, 2026.
-
Additional In-Kind Distribution
An additional 366,337 shares were disposed of via in-kind distributions to investors, as detailed in the filing.
Analysis
This Form 4 details the specific execution of a significant portion of the recently closed secondary offering by Blackstone-affiliated entities, which are major 10% owners. The open market sale of approximately $1.13 billion in shares, representing about 2.1% of Medline's market capitalization, indicates a substantial reduction in their stake. This follows the broader trend of private equity firms, including Carlyle and Hellman & Friedman, monetizing their investments in Medline Inc. following its IPO. While expected as part of the secondary offering, the sheer scale of the disposition by these institutional investors could contribute to an overhang on the stock.
At the time of this filing, MDLN was trading at $41.07 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $54B. The 52-week trading range was $38.00 to $50.88. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.